Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that the company will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026 at 8:30 a.m. GMT / 3:30 a.m. ET.